Decoy Therapeutics is trading 5.3% up at $4.07, with no confirmed company-specific announcement or Q2 earnings release found for August 11, 2026.

  • The company website lists August 3, 2026, as its latest release.
  • Major indexes were modestly lower, offering no clear explanation for the gain.
  • The move may reflect speculative trading or anticipation surrounding the reported earnings preview; causation remains unconfirmed.